title: Can RAS inhibitors affect the course of hypertrophic cardiomyopathy?
authors.affiliation: Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Liverpool L14 3PE, UK. Electronic address: Rob.Cooper@lhch.nhs.uk.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Cooper
authors.affiliation: Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Liverpool L14 3PE, UK.
authors.forename: Rodney H
authors.initials: RH
authors.lastname: Stables
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy*; D019808:Losartan / Q000627:therapeutic use*; D008297:Male
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D019808:Losartan